However, under conditions of repetitive challenge with cognate cancer cells, CEA-28ζ-I1 CAR T cells with IRF4 downregulation showed superior cancer cell elimination compared with conventional CAR T cells. This evidence concerns the gene CEACAM5 and cancer.